Skip to main content
. 2011 Apr 25;29(16):2282–2290. doi: 10.1200/JCO.2010.33.2023

Fig 3.

Fig 3.

Kaplan-Meier plot of patients from the Cancer and Leukemia Group B 9840 trial showing progression-free survival split by inclusion in the tissue microarray (TMA). Note that patients selected for inclusion in the TMA show statistically significant better outcome than patients not included in the TMA. HR, hazard ratio.